What is Opus Genetics's current ratio?

Opus Genetics (IRD) reported current ratio of 7.1× in Q1 2026.

How has Opus Genetics's current ratio changed year-over-year?

Opus Genetics's current ratio increased by 260.8% year-over-year, from 2× to 7.1×.

What is the long-term trend for Opus Genetics's current ratio?

Over 5 years (2020 to 2025), Opus Genetics's current ratio has grown at a 3.0% compound annual growth rate (CAGR), from 5.5× to 6.4×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Opus Genetics IRD Current ratio

Current ratio at other companies

AbbVieABBV

0.8×0.0×

MeiraGTx Holdings plcMGTX

0.5×-1.0×

4D Molecular TherapeuticsFDMT

9.3×-3.0×

Opko HealthOPK

3.6×+1.1×

Kodiak Sciences IncKOD

3.5×-1.1×

Regeneron PharmaceuticalsREGN

3.6×-1.4×

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Where this comes from

Calculated from Opus Genetics’s reported figures.

total current assets/total current liabilities=7.1×

Based on the most recent quarter.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's current ratio?: Opus Genetics (IRD) reported current ratio of 7.1× in Q1 2026.
How has Opus Genetics's current ratio changed year-over-year?: Opus Genetics's current ratio increased by 260.8% year-over-year, from 2× to 7.1×.
What is the long-term trend for Opus Genetics's current ratio?: Over 5 years (2020 to 2025), Opus Genetics's current ratio has grown at a 3.0% compound annual growth rate (CAGR), from 5.5× to 6.4×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.